Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

Lignende værker

• Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
  af: Cazzaniga, M. E., et al.
  Udgivet: (2016)
• Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study
  af: Cerrito, Maria Grazia, et al.
  Udgivet: (2018)
• Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
  af: Gampenrieder, Simon P., et al.
  Udgivet: (2010)
• Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted
  af: ROSSI, DAVID, et al.
  Udgivet: (2020)
• Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
  af: Jung, Yun Hwa, et al.
  Udgivet: (2017)